ResearcherUniversity of CopenhagenActive in the last 2 years

Ismail Gögenür

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-3753-268X; OpenAlex author ID A5073989413.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 2 (principal investigator on 2)
Grants: 0
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 trial · 2023: none · 2024: 1 trial · 2025: none · 2026: 1 paper

Papers 2

Cyclooxygenases in pancreatic ductal adenocarcinoma: are they inflammatory catalysts for tumor growth. Last author DOI 10.3389/fonc.2026.1916208 ↗
The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. Last author DOI 10.1016/j.ejca.2020.03.013 ↗

Trials 2

Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. Principal investigator NCT06145074 ↗
Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer Principal investigator NCT05435053 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Adile Orhan · 2 shared papers, 2020–2026
- Paper Cyclooxygenases in pancreatic ductal adenocarcinoma: are they inflammatory catalysts for tumor growth. DOI 10.3389/fonc.2026.1916208 ↗
- Paper The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. DOI 10.1016/j.ejca.2020.03.013 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.